Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a global leader in providing a wide range of scientific instruments, laboratory equipment, reagents, and consumables. The company operates through four main segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Its Life Sciences Solutions segment supports biological and medical research, drug and vaccine production, and disease diagnostics across various sectors, including pharmaceuticals and biotechnology. The Analytical Instruments segment offers advanced tools and services for laboratory and field applications, catering to diverse markets such as environmental and clinical laboratories. The Specialty Diagnostics segment provides a variety of immunodiagnostic products and healthcare solutions, while the Laboratory Products and Services segment supplies essential equipment and consumables for research and clinical laboratories. Founded in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is committed to enabling customers to enhance health, safety, and productivity through innovative technologies and services.

Daniella Cramp

Senior Vice President and President

Kent Davidson

Global Vice President Commercial

Glyn Davies

Vice President and GM, Semiconductor Materials and Structural Analysis

Alan J. Malus

President of the New Analytical Technologies Group

Jelto Swaving

Director of Business Management

72 past transactions

Solventum - Purification & Filtration Business

Acquisition in 2025
Solventum - Purification & Filtration Business is a unit of Solventum that offers filters and membranes for use in the manufacturing of biopharmaceutical and medical technologies, microelectronics food, beverage products, and drinking water.

miDiagnostics

Series D in 2024
miDiagnostics is a Belgian company focused on creating innovative testing solutions that allow individuals to perform blood analyses independently. The company is developing a novel chip-based technology that enables the rapid detection of various biomarkers from minimal blood samples, such as those obtained from a finger prick. This technology integrates a nanofluidic processor with a compact reader, facilitating the measurement of cells, proteins, nucleic acids, and small molecules. By providing disposable tests that are easy to use and offer built-in connectivity, miDiagnostics aims to enhance diagnostic capabilities for both patients and clinicians, making lab-quality testing accessible anytime and anywhere.

CytoReason

Series B in 2024
CytoReason is a biotechnology company that specializes in developing a cell-centered computational model of the human body to analyze complex biological data. By collecting proprietary information from pharmaceutical companies, CytoReason simulates human diseases at both the tissue and cellular levels. Its advanced platform utilizes machine learning to reconstruct cellular information from bulk tissue, training an immune-specific engine and integrating multi-omics data. This approach enables pharmaceutical and biotech companies to gain mechanistic insights into the immune system, facilitating the discovery and development of targeted therapies. The company's innovative technology helps shorten clinical trial phases, reduce development costs, and increase the likelihood of successful regulatory approval.

Olink

Acquisition in 2023
Olink Holding AB is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

CorEvitas

Acquisition in 2023
CorEvitas is a provider of clinical registry data and analytics services focused on the biopharmaceutical sector. Established in 2000 and headquartered in Waltham, Massachusetts, the company specializes in delivering real-world evidence through its extensive registry data, which includes insights on patient experiences and outcomes. CorEvitas operates six autoimmune registries across the United States, Canada, and Japan, collecting data from over 400 participating investigator sites. The company ensures the accuracy and completeness of its data through rigorous quality control processes before it is stored in a secure data warehouse. Additionally, CorEvitas conducts active safety surveillance to support regulatory commitments for new drug approvals, contributing to post-authorization safety studies. The company's mission is to advance patient care and improve treatment through comprehensive real-world data analysis.

MarqMetrix

Acquisition in 2023
MarqMetrix, Inc. is a prominent developer of optical sensor technology, specializing in measurement systems that deliver accurate and repeatable data across various applications, including environmental, biological, chemical, and industrial fields. The company is dedicated to enhancing process improvement through the design and development of advanced optical sensors and data analysis solutions. By employing cloud-based systems, MarqMetrix enables real-time monitoring and control, which provides businesses with valuable insights to optimize their operations.

The Binding Site Group

Acquisition in 2022
Binding Site is a Specialist Protein company committed to the research, development, manufacture and distribution of innovative immunodiagnostic assays for the global laboratory market. With extensive expertise in antibody specificity technology, Binding Site gives clinicians and laboratory staff the tools to significantly improve diagnosis and management of patients across a range of cancers and immune system disorders.

Ionpath

Corporate Round in 2022
IonPath Inc., established in 2014 and headquartered in Menlo Park, California, specializes in multiplexed ion beam imaging services for pathology. The company's core technology surpasses light microscopy, enabling it to analyze fresh, frozen, or FFPE tissues with high precision. This allows healthcare providers to diagnose cancer more accurately, ultimately improving human health through better insights into the tissue microenvironment at a single-cell level.

PeproTech

Acquisition in 2022
PeproTech is a prominent developer and manufacturer of recombinant cytokines and growth factors, established in 1988 by a group of scientists focused on advancing life-science research. The company specializes in providing high-quality cytokine products derived from E. coli, insect, and mammalian cells, as well as monoclonal and polyclonal antibodies, ELISA development kits, and cell culture media and supplements. PeproTech’s extensive product line supports various fields, including cellular therapy and regenerative medicine, catering to researchers globally from offices in multiple countries. To meet the increasing demand and stay aligned with scientific advancements, PeproTech has expanded its production capabilities to include a 5000 sq. ft. animal-free manufacturing facility. The company actively collaborates with researchers in academia and industry to continually enhance its product offerings and address specific research needs. PeproTech is committed to maintaining competitive pricing while also broadening its distribution network to reach additional markets.

PharmaFluidics

Acquisition in 2021
PharmaFluidics is a Brussels-based spin-off from the Vrije Universiteit Brussel, focusing on developing and manufacturing micro-chip based chromatography columns for use in biomarker, diagnostics, and drug research applications. The company leverages its expertise in chemical engineering and micro-fabrication technology to create high-quality solutions tailored for mixing, separation, and reaction processes at milli- to nano-scales. Their products enable researchers to identify active compounds in complex biological samples more efficiently and sensitively.

PharmaFluidics

Acquisition in 2021
PharmaFluidics is a Brussels-based spin-off from the Vrije Universiteit Brussel, focusing on developing and manufacturing micro-chip based chromatography columns for use in biomarker, diagnostics, and drug research applications. The company leverages its expertise in chemical engineering and micro-fabrication technology to create high-quality solutions tailored for mixing, separation, and reaction processes at milli- to nano-scales. Their products enable researchers to identify active compounds in complex biological samples more efficiently and sensitively.

PPD

Acquisition in 2021
PPD, Inc. is a global provider of drug development services tailored for the biopharmaceutical industry. The company operates through two primary segments: Clinical Development Services and Laboratory Services. Its clinical development offerings encompass a wide range of services, including product development, consulting, and management of clinical trials spanning Phases II-IV, as well as medical communications and post-approval support. In addition, PPD's laboratory services include bioanalytical testing, biomarker research, vaccine science, and good manufacturing practices. With a commitment to enhancing the efficiency of drug development, PPD collaborates with various clients, including pharmaceutical, biotechnology, and medical device companies, as well as academic institutions and government organizations. Established in 1985, PPD is headquartered in Wilmington, North Carolina.

WuXi Diagnostics

Series B in 2021
WuXi Diagnostics specializes in clinical diagnostic services that facilitate the transition of testing solutions from research to clinical practice. The company focuses on innovative models that enhance diagnostic product development and generate valuable clinical insights. By offering a range of services, including screening and early diagnosis, clinical decision support, and prognosis management, WuXi Diagnostics aims to improve healthcare outcomes through precision diagnosis and treatment. Their commitment to advancing diagnostic capabilities positions them as a significant player in the healthcare industry, ultimately benefiting public health.

Mesa Biotech

Acquisition in 2021
Mesa Biotech, Inc. is a San Diego-based company that specializes in the design, development, manufacturing, and commercialization of molecular diagnostic tests aimed at infectious diseases. Founded in 2015, the company has developed innovative products such as the Accula Dock, which manages critical testing parameters, and various Accula test cassettes for detecting influenza and respiratory syncytial virus. Mesa Biotech's technology simplifies DNA and RNA molecular testing, merging the convenience of point-of-care testing with the sensitivity and specificity typically associated with laboratory-based diagnostics. This enables healthcare professionals to obtain actionable, laboratory-quality results directly at the point of care, enhancing the efficiency of disease management and treatment. The company also operates a satellite testing laboratory in Santa Fe, New Mexico.

Henogen

Acquisition in 2021
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.

Phitonex

Acquisition in 2020
Phitonex, Inc. is a biotechnology company based in Durham, North Carolina, focused on developing advanced fluorescent reagents and instrumentation for molecular biomarker analysis. Founded in 2017 as a spin-out from Duke University, Phitonex specializes in creating a suite of fluorescent labels, including Novafluor, Infinifluor, and Infinisight, which enhance the capability of high-throughput flow cytometry. By engineering optical properties at the molecular level, Phitonex's products enable high-resolution analysis of individual cells and allow for the simultaneous observation of multiple biomarkers. The company's innovative solutions are designed to facilitate more cost-effective and non-destructive research methodologies, thereby accelerating discoveries in disease understanding and treatment. As of December 31, 2020, Phitonex operates as a subsidiary of Thermo Fisher Scientific Inc.

HighChem

Acquisition in 2019
HighChem Ltd. is a Slovakian company established in 1998 and headquartered in Bratislava, specializing in the design and development of mass spectrometry software solutions. As a subsidiary of Thermo Fisher Scientific Inc., HighChem focuses on providing chemists, medical researchers, and biologists with advanced tools to interpret complex analytical data effectively. The company creates extensive data collections that include fragmented information, experimental spectra, and organism-specific biochemical data, which are critical for various applications in metabolomics, pharmacology, forensics, and environmental studies. Additionally, HighChem develops library and cloud platforms to enhance the accessibility and utility of its software solutions.

Brammer Bio

Acquisition in 2019
Brammer Bio, LLC specializes in the development and manufacturing of cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, and clinical and commercial supply of drug substances and formulated products. Brammer Bio focuses on supporting the production of autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications. With facilities in Alachua, Florida, and plans for a new site in Lexington, Massachusetts, the company aims to enhance its capacity for large-scale manufacturing and clinical support. As a contract development and manufacturing organization, Brammer Bio collaborates with biopharma clients to facilitate the delivery of innovative therapies, ensuring regulatory compliance and accelerating the commercialization of novel medicines.

IntegenX

Acquisition in 2018
IntegenX Inc. is a developer of innovative human DNA identification solutions headquartered in Pleasanton, California. Founded in 2003, the company specializes in rapid DNA technology for forensics and law enforcement applications. IntegenX's technology platforms integrate advanced fluidics, optics, biochemistry, and software to create automated sample-to-answer products for human identity testing. The company offers a range of products, including the RapidHIT System, which delivers standardized DNA profiles from various human samples, and the RapidHIT GlobalFiler Express Kit for processing crime scene samples directly within the cartridge. Additionally, IntegenX provides other tools like the Apollo series for DNA sequencing and sample preparation. The company distributes its products in multiple international markets, enhancing capabilities in human identification for law enforcement agencies worldwide.

Linkage Biosciences

Acquisition in 2017
Linkage Biosciences, Inc. is a molecular diagnostics company focused on developing and marketing products that enhance and accelerate complex genetic testing. Established in 2004 and headquartered in South San Francisco, California, with an office in Geneva, Switzerland, the company specializes in human leukocyte antigen (HLA) testing products used primarily in solid organ and hematopoietic stem cell transplantation. Its product offerings include a range of HLA typing kits, killer-cell immunoglobulin-like receptor (KIR) typing kits, and human platelet antigen (HPA) typing kits, along with accessories to facilitate testing procedures. Linkage Biosciences aims to improve diagnostic capabilities in areas such as autoimmune disease testing, pharmacogenomics, and genetic marker testing. As of July 2017, the company operates as a subsidiary of One Lambda, Inc., and has established a network of distributors in various countries, including Austria, Greece, Italy, and South Korea.

Patheon

Acquisition in 2017
Patheon Inc. is a provider of comprehensive pharmaceutical development and manufacturing services tailored for the pharmaceutical and biotechnology sectors worldwide. Established in 1974 and headquartered in Mississauga, Canada, the company specializes in the manufacture of prescription and over-the-counter products across various dosage forms, including solid, semi-solid, liquid, and sterile formats. Patheon's service offerings encompass the entire lifecycle of pharmaceutical products, beginning with early development and continuing through to commercial manufacturing. These services include specialized capabilities in high-potency compounds, sterile production, lyophilization, and controlled-release formulations, as well as logistics and packaging solutions. Additionally, Patheon aids clients in the drug approval process by providing contract development services, which involve pre-formulation, analytical method development, and the manufacture of pilot batches, alongside clinical packaging and technology transfer services to support commercial-scale operations. The company operates globally, delivering products to approximately 120 countries.

Core Informatics

Acquisition in 2017
Core Informatics, LLC is a software company based in Branford, Connecticut, that specializes in data management solutions tailored for scientific research and collaboration. Founded in 2005, the company provides a range of products, including Core LIMS, Core ELN, and Core SDMS, which facilitate laboratory information management, electronic lab notebook functionalities, and automated data capture, respectively. Their Platform for Science serves as a comprehensive lab informatics platform, enabling rapid configuration and deployment of various applications and ensuring seamless integration with existing IT environments. Additionally, Core Collaboration offers secure data exchange and storage solutions for teams worldwide. The company’s software is utilized by diverse industries such as pharmaceuticals, diagnostics, energy, and manufacturing, allowing clients to manage data effectively and derive valuable insights from their scientific endeavors.

Finesse Solutions

Acquisition in 2017
Finesse Solutions, Inc., established in 2005 and headquartered in Santa Clara, California, specializes in manufacturing measurement and control solutions for life sciences processes. The company offers a range of products including single-use and sterilizable sensors, bioreactor controllers, software for upstream bio-processing (TruBio), labscale and cGMP glass vessels, equipment setup services, training programs, and bioprocessing solutions such as SmartFactory and SmartSystems. These solutions aim to optimize plant-wide resource utilization, improve batch-to-batch reproducibility, and facilitate technology transfer. Finesse Solutions operates globally with offices in the US, China, UK, South Korea, and Singapore, serving as a subsidiary of Fisher Scientific Worldwide Holdings I C.V. since 2017.

MTI-GlobalStem

Acquisition in 2016
MTI-GlobalStem has an active research program that utilizes expertise in transfection, neuroscience and stem cell biology to develop and supply scientists with the necessary tools and reagents to help advance new discoveries and developments in the life sciences. Utilizing our intellectual property and know-how, and a specialized team of highly skilled and experienced scientists, we are filling the gap with primary and iPSC-derived neural cells, stem cells and supporting feeder cells, optimized growth media and supplements, and an innovative platform of novel targeted reagents used to deliver nucleic acids into stem cells and neuronal cells with maximum efficiency.

FEI Company

Acquisition in 2016
FEI Munich specializes in advanced microscopy solutions, leveraging over 60 years of innovation in the field. The company designs and manufactures a wide array of high-performance microscopy systems that cater to micro-, nano-, and picometer-scale applications. FEI Munich is particularly focused on life sciences, providing products and services for fluorescence microscopy that are essential in fundamental research, applied science, and diagnostics. By offering comprehensive microscopy workflow solutions, the company enables customers to obtain critical insights and answers that facilitate significant discoveries and enhance productivity across various scientific domains.

INEL

Acquisition in 2016
INEL was incorporated in 1984 and converted into a joint venture in 1986 between Lucas Indian Service Ltd, a wholly-owned subsidiary of Lucas-TVS Ltd and MAHLE Electric Drives Japan Corporation, Japan - a company of MAHLE Group, Germany, to manufacture Electronic Ignition Systems for two-wheelers, three wheelers and portable engines. Over the years the company has enlarged its customer base and now supplies to most of the manufacturers of two-wheelers, three wheelers and gensets. Company's net sales for the year ended March, 2015 was Rs.3274 Million (USD 50 Million). INEL makes the entire range of 2/3 wheelers, digital and analog ignition products.

Affymetrix

Acquisition in 2016
Affymetrix is a company that specializes in developing and providing advanced technologies for the analysis of biological systems at the gene, protein, and cell levels. Its products are designed to facilitate genetic analysis within the life sciences and clinical healthcare markets. Affymetrix offers a range of life science tools and diagnostic products, including gene expression and genotyping services, which support both clinical diagnostics and research applications. By enabling comprehensive analysis of biological data, Affymetrix plays a significant role in advancing the understanding of molecular biology and improving healthcare outcomes.

Alfa Aesar

Acquisition in 2015
Alfa Aesar, a subsidiary of Johnson Matthey, is a prominent manufacturer and supplier of research chemicals, metals, and materials used in various applications. Over its fifty-plus years of operation, the company has established itself as a reliable source for high-purity raw materials essential for research and development. With a diverse product portfolio exceeding 45,000 items, Alfa Aesar provides everything from gram-scale catalog products to semi-bulk and bulk production quantities. Their offerings include inorganic, organic, and organometallic compounds; pure metals; precious metal compounds; biochemicals; fuel cell products; nanomaterials; rare earth elements; analytical products; and selected laboratory equipment. Catering to industries such as pharmaceuticals and electronics, as well as academic institutions, Alfa Aesar emphasizes product quality, availability, and timely delivery, ensuring a high level of customer service. Most catalog items are available for same-day shipment, supported by a knowledgeable staff dedicated to meeting and exceeding customer expectations.

Advanced Scientifics (ASI)

Acquisition in 2015
Advanced Scientifics is a prominent global provider of advanced single-use systems tailored for the Healthcare and Life Sciences sectors. The company specializes in manufacturing customized systems and equipment that facilitate the preparation, processing, diagnostics, storage, and transportation of biopharmaceuticals. Headquartered in Pennsylvania, the company also operates an additional production facility in Matamoros, Mexico, enhancing its capacity to serve clients worldwide. Through its innovative offerings, Advanced Scientifics supports the growing demands of the bioprocessing industry.

Prionics

Acquisition in 2014
Prionics is a leading provider of diagnostic solutions for farm animals, specializing in disease detection and management. The company has evolved from its origins in BSE testing to offer a comprehensive range of diagnostic kits and tools designed to meet the diverse needs of its international clientele. Prionics' portfolio includes products for the electronic and visual identification of farm animals and pets, as well as forensic DNA sampling devices for use in criminal investigations. Additionally, the company supplies biochemical reagents for both diagnostic and research applications. By continuously expanding its offerings along the food value chain, Prionics addresses unique diagnostic challenges and aims to enhance animal health and safety globally.

Life Technologies

Acquisition in 2014
Life Technologies Corporation is a biotechnology tools company formed in November 2008 from the merger of Invitrogen Corporation and Applied Biosystems, Inc. The company operates under these well-known brands, providing a comprehensive range of systems, consumables, and services that facilitate scientific research and development. Invitrogen specializes in reagents and consumables applicable across various platforms, while Applied Biosystems offers integrated solutions in critical areas such as polymerase chain reaction (PCR), genetic sequencing, and mass spectrometry. Life Technologies' diverse product portfolio includes technologies for capillary electrophoresis-based sequencing, sample preparation, cell culture, RNA interference analysis, functional genomics, proteomics, and cell biology, in addition to applications in clinical diagnostics and water testing analysis. Through its offerings, Life Technologies supports researchers in accelerating their scientific endeavors.

picoSpin

Acquisition in 2012
picoSpin, LLC, based in Boulder, Colorado, was founded in 2010 by Charles E. Miller and a team of scientists and engineers. The company specializes in the development, manufacture, and marketing of miniature nuclear magnetic resonance (NMR) spectrometers. picoSpin's products provide rapid and cost-effective access to analytical spectroscopy, making them valuable for chemists in various fields. Their applications include quality analysis, quality control, chemical education, and process development. In addition to NMR spectrometers, picoSpin also produces replacement capillary cartridges and other fluid instruments tailored for the chemical engineering industry.

One Lambda

Acquisition in 2012
One Lambda is a manufacturer of transplant diagnostics products based in Los Angeles, California. The company specializes in developing and distributing a range of histocompatibility (HLA) typing tests that utilize both serological and molecular technologies. In addition to HLA typing tests, One Lambda produces a comprehensive array of antibody detection products, laboratory instruments, and software designed to streamline and automate testing procedures and evaluations. These innovations are crucial for pre- and post-transplant monitoring, supporting the medical community in ensuring successful transplant outcomes.

Princeton Security Technologies

Acquisition in 2012
Princeton Gamma-Tech Instruments is a leading supplier of X-ray and Gamma-ray Detectors and Spectroscopy systems, portable Radioisotope Identifiers, and portable Chemical Analyzers. We serve a broad customer base in scientific research, industrial materials analysis, and Home Land Security. PGT operates a full customer service and Reachback program, backed by a modern manufacturing and service facility. Princeton Gamma-Tech has been a leader in the field of semiconductor gamma- and X-ray detectors for over 30 years. When General Electric first produced high-purity (intrinsic) germanium crystals in 1972-73, PGT manufactured the first commercial HPGe planar detectors, soon followed by the first HPGe coaxials. Since that time, PGT HPGe detectors have explored outer space, gone to the depths of mines in search of beta-beta decay in enriched germanium, and found uses throughout the world in nuclear power plants, environmental measurements, and aerospace studies.

Doe & Ingalls Management

Acquisition in 2012
Doe & Ingalls Management is a distributor of specialty chemicals that serves the life sciences and microelectronics sectors. The company provides a wide range of products including cGMP buffer salts and solutions, disinfectants, cleaning solutions, photoresists, developers, strippers, edge bead removers, etchants, acids, solvents, and laboratory reagents. In addition to its chemical offerings, Doe & Ingalls emphasizes the importance of building secure, robust, and transparent supply chains, offering complementary supply chain services and market insights to its clients. This comprehensive approach positions the company as a key partner in supporting biopharmaceutical processes and electronic component manufacturing.

Intrinsic Bioprobes

Acquisition in 2011
Intrinsic Bioprobes, established in 1996 and based in Tempe, Arizona, is a biotechnology company specializing in the development of immuno-enrichment and sample-preparation tools used in quantitative mass spectrometry. The company also focuses on creating clinical diagnostic assays and platforms designed for rapid and sensitive protein biomarker analysis. Additionally, Intrinsic Bioprobes offers industrial-scale protein analysis services to investigate proteins detectable in human biological fluids.

Trek Diagnostic Systems

Acquisition in 2011
Trek Diagnostic Systems specializes in the manufacture of automated systems and equipment for microbiology-based diagnostic testing. As a part of Thermo Fisher Scientific, the company focuses on developing analytical instruments and innovative technologies for immune diagnostic testing, as well as monitoring air and water quality and process control. By providing these advanced tools and solutions, Trek aims to assist customers in making the world healthier, cleaner, and safer. Its clientele includes pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions, and government agencies, all of which benefit from Trek's commitment to enhancing diagnostic capabilities and environmental safety.

Phadia

Acquisition in 2011
At Phadia, they develop, manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. For more than 40 years, they have been focused on delivering results, and they are proud to report that, in that time, they have maintained leadership in allergy testing and become one of the world's leading autoimmune disease test providers. Headquartered in Uppsala, Sweden, their international centre of excellence is at the heart of it all. The site of their strategic management, administration and business development activities, it’s also the home of extensive research and development as well as world-class manufacturing facilities. They also have a site in Southern Sweden, where development of their allergen raw materials takes place. In Freiburg, Germany, a third centre of excellence develops, manufactures and supports diagnostic tests for autoimmune diseases. Recently, a fourth centre of excellence was established in Vienna, Austria, to handle the development and production of assay systems, based on multiplex technology, for both allergy and autoimmunity. Together, these four centres enable us to remain focused on excellence as they respond to the diagnostic needs of the world.

Sterilin

Acquisition in 2011
Sterilin Limited is a manufacturer and supplier of disposable plastic products tailored for the life science, microbiology, and clinical markets. The company specializes in a variety of single-use plastic ware, including petri dishes, sample containers, pipettes, and multiwell plates. In addition to these laboratory essentials, Sterilin offers packaging solutions featuring regular bottles made from HDPE, LDPE, or PP, equipped with dispensing, child-resistant, and tamper-evident closures. The company's product range also includes moulded and extruded silicone items, such as cones, discs, pipette bulbs, sheeting, stoppers, test tube holders, and tubing, catering to diverse needs within the clinical and laboratory sectors.

TKA Wasseraufbereitungssysteme

Acquisition in 2010
TKA Wasseraufbereitungssysteme GmbH specializes in the design and manufacture of laboratory water purification systems. The company provides a comprehensive range of products, including ion exchange cartridges, reverse osmosis systems, ultrapure and high purity water systems, as well as pretreatment systems and water softeners. In addition to these main offerings, TKA also supplies various laboratory equipment and consumables, such as mixed-bed resins, activated carbon filters, and measuring instruments. Their focus on quality and precision ensures that customers receive reliable solutions for their water purification needs.

Dionex

Acquisition in 2010
Dionex Corporation is a leading manufacturer of chromatography and extraction systems designed for the separation, isolation, and identification of components within chemical mixtures. The company's products are utilized globally across various sectors, including environmental analysis, life sciences, pharmaceuticals, food and beverage, chemicals, power generation, and electronics. By focusing on innovative solutions, Dionex supports laboratory research and testing, enhancing productivity in industries that are vital to global infrastructure and public health.

Lomb Scientific

Acquisition in 2010
Lomb Scientific is a prominent manufacturer and distributor of laboratory consumables, chemicals, and instrumentation for the scientific community. Originally established as a niche supplier of microscope slides and coverslips, the company has evolved significantly since its acquisition by Walter Parsons in 1984. Under his leadership, Lomb Scientific expanded its operations, relocating to larger, purpose-built facilities and establishing additional offices and warehouses across Australia and New Zealand. The company has experienced rapid growth, particularly through strategic acquisitions, including Scot Scientific, Fronine, and Ajax Finechem, which have enhanced its product offerings and regional coverage. Scot Scientific bolstered Lomb's presence in Western Australia, while Fronine improved the manufacturing and supply of pathology stains and solvents. Ajax Finechem strengthened the company's portfolio of exclusive brands in chemicals and solvents. Today, Lomb Scientific aims to advance scientific research and development by providing comprehensive support and high-quality products to its clients.

Fermentas International

Acquisition in 2010
With origins dating back to the 1970s, Fermentas produced molecular biology products for scientific research. Fermentas grew to be the dominant player in Europe, and sought an experienced life sciences partner to solidify this leading position while helping expand geographically into North America and Asia.

Polychromix

Acquisition in 2010
Polychromix is an advanced communications technology company specializing in the development and manufacture of optical subsystems and chemical sensing products. The company's portfolio includes innovative technologies that enable dynamically configurable optical networks. Notably, Polychromix offers PHAZIR, a near-infrared material analyzer designed for various applications such as raw material inspection, quality control, field testing, and counterfeit product identification.

Proxeon

Acquisition in 2010
Proxeon specializes in developing innovative solutions for the field of proteomics, addressing various scientific and technical challenges. With over 15 years of experience in proteomics research, the company has established a strong reputation for creating high-quality products. Proxeon focuses on mass spectrometry, protein analysis, and the design of both hardware and software tailored for proteome analysis. Their offerings include medical devices for sample purification, which enhance proteomic workflows by emphasizing performance, robustness, simplicity, and user-friendliness. By leveraging their extensive expertise, Proxeon contributes to advancing proteomics tools and technologies.

NovaWave Technologies

Acquisition in 2010
NovaWave Technologies, established in 2002, specializes in the development of optically-based chemical detection instrumentation. The company serves both military and civilian markets, with applications including homeland defense, environmental monitoring, metrology, and research. Additionally, NovaWave is advancing novel microfluidic systems for biomedical uses such as clinical diagnostics and biological agent detection. With a team comprising experts in science, management, and marketing, the company has forged strategic partnerships with industry leaders to produce cost-effective, high-performance sensor systems for global markets.

Finnzymes Oy

Acquisition in 2010
Finnzymes Oy specializes in the development and manufacturing of scientific instruments and high-quality enzymes for molecular biology applications. Established in 1986, the company is recognized for its expertise in polymerase chain reaction (PCR) technologies, including reverse transcription-PCR (RT-PCR) and real-time quantitative PCR (qPCR). Finnzymes aims to enhance the performance of these enzymes to support various applications, such as genomic research, genetic testing, forensics, and food testing. The company emphasizes ongoing research and development to provide innovative tools that meet the needs of the molecular biology community. With a strong foundation in scientific excellence, Finnzymes also offers competitive pricing and responsive technical support, contributing to its reputation as a leader in enzyme innovation in Finland.

Ahura Scientific

Acquisition in 2010
Ahura Scientific Inc. specializes in developing rugged, ultra-compact, field-enabled optical systems designed for the immediate identification and authentication of liquid and solid chemical substances. The company provides handheld Raman spectrometers that are particularly suited for raw material identification and finished product authentication in the pharmaceutical and consumer health sectors. Its technology is utilized across various industries, including homeland security, life sciences, industrial applications, and medical devices, focusing on chemical and explosives identification, material verification, and anti-counterfeiting efforts. Manufactured in the USA within an ISO 9001-certified facility, Ahura Scientific's products are recognized for their exceptional portability and high performance.

B.R.A.H.M.S.(Brahms)

Acquisition in 2009
B.R.A.H.M.S. specializes in the development and production of diagnostic test procedures aimed at enhancing the diagnosis and treatment of life-threatening illnesses. With a workforce of over 400 employees, the company utilizes its patented biomarkers to deliver superior diagnostic insights for both patients and medical professionals. B.R.A.H.M.S. focuses on various medical applications, including bacterial infections, sepsis, cardiovascular disease, and neurological disorders. Its products are distributed in over 65 countries, establishing the company as a leader in its specialized markets.

Biolab

Acquisition in 2009
Biolab Limited supplies laboratory products and analytical technologies to clients in Australia and New Zealand. It offers clinical diagnostic testing products, diagnostic imaging products, environmental monitoring and safety products, medical devices and consumables, process monitoring and industrial instruments, laboratory chemicals, laboratory equipment and furniture, life science research technologies, microbiology products, pathology equipment and supplies, and scientific instruments and automation solutions, as well as laboratory plasticware, glassware, and supplies.

ABR--Affinity BioReagents

Acquisition in 2008
ABR--Affinity BioReagents, Inc. is a manufacturer and distributor of monoclonal and polyclonal antibodies, as well as recombinant proteins, serving the scientific research community. The company offers a diverse range of products, including cell biology reagents that cover apoptosis, cell adhesion, structure markers, and cytokines; cell signaling tools such as bioactive peptides and various receptors; and additional items like blocking peptides and secondary antibodies. Furthermore, ABR provides specialized reagents and immunology services across areas like muscle biology, nuclear biology, neurobiology, and stem cell biology. Founded in 1989 and based in Golden, Colorado, the company distributes its products through a global network of partners, ensuring accessibility to researchers in numerous countries around the world. ABR operates as a subsidiary of Pierce Biotechnology Inc.

NanoDrop Technologies

Acquisition in 2007
NanoDrop Technologies is a manufacturer based in Wilmington, Delaware, specializing in micro-volume analytical instruments that utilize patented sample retention technology. The company develops and sells micro-volume ultraviolet-visible spectrophotometers and fluorospectrometers, enabling precise photometric analysis of 1 µL samples. Originally developed at the DuPont Agricultural Genomics Laboratories, this technology has been in use since 1998 and is widely adopted in biotechnology, pharmaceutical, and life science research sectors globally. NanoDrop Technologies is recognized for its innovative solutions that facilitate efficient and accurate analysis in laboratory settings.

Priority Solutions International

Acquisition in 2007
Priority Solutions International is a company specializing in global supply chain management services, primarily serving the pharmaceutical, consumer healthcare, and testing industries. The organization provides a range of logistics solutions, including warehousing, order management, shipment preparation, and international air freight forwarding. Additionally, it offers regulatory compliant distribution services, which encompass controlled substances and emergency response services, as well as reverse logistics. Through its comprehensive suite of services, Priority Solutions International aims to meet the complex needs of its clients in a highly regulated environment.

Cohesive Technologies

Acquisition in 2007
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.

Spectronex

Acquisition in 2007
Spectronex is a leading supplier of mass spectrometry, chromatography and surface science instrumentation in Switzerland, Austria, Slovakia and the Czech Republic.

Flux Instruments

Acquisition in 2007
In 1992 Flux Instruments was founded in the small industrial town of Karlskoga in Sweden. The founders predicted an increasing potential for their novel HPLC pump, based on a radically new concept. It's secret? Hitherto unknown miniaturization techniques lead to unsurpassed precision and microflow capabilities. With its R&D department near Munich in Germany and its manufacturing site in Sweden and Switzerland. Technology leadership and precision manufacturing have been given the highest priority. They will continue their innovative strategies and make sure to also fulfill your needs in the years to come. High-Pressure-Liquid-Chromatography has outstanding worldwide growth, probably outperforming all other types of analytical instruments. In combination with MS has, the use of microbore and capillary columns already are state-of-the-art, other areas in HPLC are likely to follow. The necessity to deliver gradient HPLC flow in the low micro-and even nanoliter range has been their challenge from the beginning. Today they offer the No. 1 system for microbore HPLC and have clear leadership in this market segment. Whether for applications in life sciences, in proteomics research, or in the area of high throughput analysis and fast analysis cycles, the miniaturized design of their instruments is the key to outstanding performance.

SwissAnalytic Group

Acquisition in 2007
SwissAnalytic Group develops and markets liquid chromatography pumps.

EGS Gauging

Acquisition in 2006
EGS Gauging Inc is one of the world's largest suppliers of measurement and control products for web process applications in the plastics processing and converting industries. They have the resources and the vision to bring their customers into the future with a full complement of innovative web gauging and control systems and services. But the proof is in the numbers: With almost 3000 EGS Gauging systems installed worldwide, and a higher than 75% repeat business rate, the clear message from OEMs and users is that EGS Gauging solutions continue to be the clear choice for quality, reliability, performance and results. From the Americas to Zimbabwe, and more than 50 countries in between, EGS Gauging systems are hard at work delivering top-of-the-line measurement performance for plants of all sizes.

Omega Data Systems

Acquisition in 2006
Netherlands-based Omega Data Systems, developer of the world renowned UniQuant XRF analysis package. UniQuant® is software for use with a sequential X-Ray Fluorescence (XRF) Spectrometer. It enables quantitative elemental analysis of samples without or with the use of standards.

Fisher BioImage

Acquisition in 2006
Fisher BioImage ApS, a life science company, develops and sells assays for monitoring protein translocations and protein interactions in living cells. It provides Redistribution technology, which helps to monitor cell-based protein translocation assays using fluorescent protein reporters. The company offers assays to pharmaceutical and biotechnology companies, as well as to academic groups for basic research.

Ambion

Acquisition in 2006
Ambion is a company that specializes in the development and sale of RNA-based reagents for life science research. They offer a range of molecular biology products, including enzymes and other tools essential for drug development and scientific investigations. Ambion's focus is on providing high-quality reagents to support advancements in life sciences.

Ionalytics Corporation

Acquisition in 2005
Sensitivity, separation and detection are critical success factors in drug discovery. At Ionalytics, they have developed the Ionalytics SelectraTM, a front-end instrument that enhances the performance of mass spectrometers by providing dynamic ion filtering to: - improve efficacy of data - reduce drug development time Based on FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) technology, the Ionalytics Selectra filters and focuses ions within a highly tuned electrical field contained within an electrode set. The result is increased productivity of mass spectrometers in both qualitative and quantitative applications. The Ionalytics team is committed to providing innovative tools to help laboratory professionals determine a drug's potential for treating or curing illness. Comprised of seasoned business leaders, respected scientists and engineers with years of product development and support expertise, their collective talent and experience has resulted in a customer-oriented culture and a high performance instrument that helps bring new drugs to market quicker.

Rupprecht & Patashnick

Acquisition in 2005
Rupprecht & Patashnick, founded in 1981 and headquartered in East Greenbush, New York, is recognized as a global leader in the development of high-performance instrumentation for continuous particulate monitoring. With a workforce of over 100 employees, the company specializes in creating innovative and reliable solutions that address the stringent demands of regulatory applications in air quality monitoring. R&P's commitment to excellence has established its reputation as a trusted provider in the field, and it is poised to become part of the Air Quality Instruments product line within Thermo's Environmental Instruments division.

Kendro Laboratory Products

Acquisition in 2005
Kendro Laboratory Products is a global leader in the design, manufacture, and marketing of laboratory equipment tailored for sample preparation, processing, and storage, primarily serving the life sciences, material science, and drug discovery sectors. The company offers a diverse range of products, including centrifuges recognized by the Sorvall and Heraeus brands, which are utilized for applications such as DNA separation and whole cell processing in various scientific fields, including biochemistry and diagnostics. Kendro also provides thermal equipment, such as ovens, incubators, freezers, and refrigerators, under the Revco and Jewett brands, catering to research and industrial needs. In addition to its equipment offerings, Kendro supports its customers with extensive services, including a global network of technicians, integrated validation services, and bio-repositories designed for sample storage and laboratory relocation management.

Oxoid

Acquisition in 2004
Oxoid is a leading manufacturer of microbiological culture media and diagnostic products, with a strong presence in Europe, North and South America, and Australia. The company develops, manufactures, and distributes a variety of media cultures and related products essential for microbiological diagnosis in clinical settings, food testing, and biopharmaceutical production. Oxoid's offerings enable laboratories to isolate and identify bacteria and other organisms, playing a critical role in ensuring product safety and quality. With a commitment to quality and customer service, Oxoid has established a strong reputation for assisting clients in preventing bacterial contamination. The company is headquartered in Basingstoke, England.

Dharmacon

Acquisition in 2004
Dharmacon, Inc., based in Lafayette, Colorado, specializes in the development and commercialization of RNA oligonucleotide synthesis technologies. The company provides a range of products including gene editing tools, RNA interference products, cDNAs, and transfection solutions, all aimed at applications such as gene knockdown, microRNA analysis, and genome editing. Renowned for its expertise in chemistry, biology, and bioinformatics, Dharmacon has introduced a custom small interfering RNA (siRNA) design service to enhance the effectiveness of gene silencing. Established in 1995, the company operates as a subsidiary of Horizon Discovery Group plc after rebranding from Dharmacon, Inc. in 2014.

Jouan SA

Acquisition in 2003
Jouan is a global supplier of products used by life science researchers in academic, pharmaceutical, biotech, and clinical markets to prepare and preserve laboratory samples. Jouan's offerings include centrifuges, biological safety cabinets, ultra-low temperature freezers, and incubators. The company has also incorporated robotics into many of its products to meet the increased throughput requirements of researchers, and is a leading provider of automated centrifuges, freezers, and incubators. In addition to its own brand name, Jouan's products are sold worldwide under the Precision, NAPCO, Heto, Holten, and ALC brands. Jouan is based in Saint-Herblain, France, and has manufacturing operations in France, Denmark, Italy, the Czech Republic, and the U.S.

Perbio Science

Acquisition in 2003
Perbio Science AB is a biotechnology company based in Helsingborg, Sweden, specializing in protein research and development. The company provides a range of products, systems, and services designed for life science researchers and biopharmaceutical companies, enabling them to produce and understand proteins more efficiently and cost-effectively. Perbio Science is structured into three divisions: the Bioresearch Division offers kits, reagents, and services for protein identification, quantification, purification, and modification, as well as nucleotides for nucleic acid-based applications; the Cell Culture Division supplies nutrition for cultured animal cells and sterile liquid processing systems; and the Medical Device Division focuses on voice rehabilitation solutions for patients who have undergone laryngectomy. As of March 31, 2003, Perbio Science employed 1,314 individuals globally, reflecting its significant role in the biotechnology sector.

CRS Robotics

Acquisition in 2002
CRS develops laboratory integration hardware and software to control motion control devices (robots). The company designs, manufactures and markets integrated laboratory workstations, laboratory peripheral products and articulated robots for a variety of laboratory and advanced manufacturing processes. Their core competence is the provision of standard automation solutions utilizing advanced proprietary software for the multi-billion dollar world biotechnology and pharmaceutical segments of the global Life Sciences market. CRS advanced software and motion control devices are used for drug discovery, gene sequencing, quality assurance and compound testing. In addition, they supply robot automation products to niche advanced manufacturing and technology markets such as product and materials testing, machine and instrument loading, dispensing and deburring, applications, and for Research and Development and Educational Institutions. CRS is a global company with sales, service and engineering centers throughout the global marketplace.

Keystone Scientific

Acquisition in 2000
Keystone was founded in 1985 by Dr. Richard A. Henry, a highly respected chromatographer with 30 years of experience, and Director of Analytical Laboratories at Penn State University. Dr. Henry is still active in the company as Technical Director, where he sets a high standard for technical support and development of innovative products. Keystone specializes in preparing packed columns for HPLC, SFC and CEC, plus the supplies and accessories that allow columns to be used properly. KSI now occupies various buildings and employs many competent, experienced chemists. The different departments of KSI work together to provide the customer with a high quality product, fast service, excellent customer service and technical support.

Thermo Hypersil-Keystone

Acquisition in 2000
Thermo Hypersil-Keystone LLC manufactures and supplies instrumentation and laboratory equipment such as packed columns and accessories for chromatography; general purpose, base deactivated, reversed and normal phase, and specialty columns for the analysis of proteins, peptides and biomolecules.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.